LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA).

    Testino, Gianni / Vignoli, Teo / Patussi, Valentino / Allosio, Pierluigi / Amendola, Maria Francesca / Aricò, Sarino / Baselice, Aniello / Balbinot, Patrizia / Campanile, Vito / Fanucchi, Tiziana / Greco, Giovanni / Macciò, Livia / Meneguzzi, Cristina / Mioni, Davide / Palmieri, Vincenzo Ostilio / Parisi, Michele / Renzetti, Doda / Rossin, Raffaella / Gandin, Claudia /
    Bottaro, Luigi Carlo / Bernardi, Mauro / Addolorato, Giovanni / Lungaro, Lisa / Zoli, Giorgio / Scafato, Emanuele / Caputo, Fabio

    Digestive diseases and sciences

    2021  Volume 67, Issue 6, Page(s) 1975–1986

    Abstract: ... disorder (AUD). In addition, alcohol-related liver disease (ALD) is the most common consequence ... manifestation of COVID-19.: Aims: The aim of our position paper was to consider some critical issues ... of the Italian Society of Alcohology (SIA) met via "conference calls" during the lockdown period to draft ...

    Abstract Background: Coronavirus Disease 2019 (COVID-19), firstly reported in China last November 2019, became a global pandemic. It has been shown that periods of isolation may induce a spike in alcohol use disorder (AUD). In addition, alcohol-related liver disease (ALD) is the most common consequence of excessive alcohol consumption worldwide. Moreover, liver impairment has also been reported as a common manifestation of COVID-19.
    Aims: The aim of our position paper was to consider some critical issues regarding the management of ALD in patients with AUD in the era of COVID-19.
    Methods: A panel of experts of the Italian Society of Alcohology (SIA) met via "conference calls" during the lockdown period to draft the SIA's criteria for the management of ALD in patients with COVID-19 as follows: (a) liver injury in patients with ALD and COVID-19 infection; (b) toxicity to the liver of the drugs currently tested to treat COVID-19 and the pharmacological interaction between medications used to treat AUD and to treat COVID-19; (c) reorganization of the management of compensated and decompensated ALD and liver transplantation in the COVID-19 era.
    Results and conclusions: The COVID-19 pandemic has rapidly carried us toward a new governance scenario of AUD and ALD which necessarily requires an in-depth review of the management of these diseases with a new safe approach (management of out-patients and in-patients following new rules of safety, telemedicine, telehealth, call meetings with clinicians, nurses, patients, and caregivers) without losing the therapeutic efficacy of multidisciplinary treatment.
    MeSH term(s) Alcoholism/complications ; Alcoholism/epidemiology ; Alcoholism/therapy ; COVID-19 ; Communicable Disease Control ; Humans ; Liver Diseases, Alcoholic/epidemiology ; Liver Diseases, Alcoholic/therapy ; Pandemics
    Language English
    Publishing date 2021-06-17
    Publishing country United States
    Document type Journal Article
    ZDB-ID 304250-9
    ISSN 1573-2568 ; 0163-2116
    ISSN (online) 1573-2568
    ISSN 0163-2116
    DOI 10.1007/s10620-021-07006-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Alcohol use disorder in the COVID-19 era: Position paper of the Italian Society on Alcohol (SIA).

    Testino, Gianni / Vignoli, Teo / Patussi, Valentino / Allosio, Pierluigi / Amendola, Maria Francesca / Aricò, Sarino / Baselice, Aniello / Balbinot, Patrizia / Campanile, Vito / Fanucchi, Tiziana / Macciò, Livia / Meneguzzi, Cristina / Mioni, Davide / Parisi, Michele / Renzetti, Doda / Rossin, Raffaella / Gandin, Claudia / Bottaro, Luigi Carlo / Caio, Giacomo /
    Lungaro, Lisa / Zoli, Giorgio / Scafato, Emanuele / Caputo, Fabio

    Addiction biology

    2021  Volume 27, Issue 1, Page(s) e13090

    Abstract: ... for the management of AUD patients in the COVID-19 era (group activities, telemedicine, outpatients treatment, alcohol ... to treat AUD and to treat COVID-19; (c) the reorganization of the Centre for Alcohol Addiction Treatment ... Coronavirus disease 2019 (COVID-19) first emerged in China in November 2019. Most governments have ...

    Abstract Coronavirus disease 2019 (COVID-19) first emerged in China in November 2019. Most governments have responded to the COVID-19 pandemic by imposing a lockdown. Some evidence suggests that a period of isolation might have led to a spike in alcohol misuse, and in the case of patients with alcohol use disorder (AUD), social isolation can favour lapse and relapse. The aim of our position paper is to provide specialists in the alcohol addiction field, in psychopharmacology, gastroenterology and in internal medicine, with appropriate tools to better manage patients with AUD and COVID-19,considering some important topics: (a) the susceptibility of AUD patients to infection; (b) the pharmacological interaction between medications used to treat AUD and to treat COVID-19; (c) the reorganization of the Centre for Alcohol Addiction Treatment for the management of AUD patients in the COVID-19 era (group activities, telemedicine, outpatients treatment, alcohol-related liver disease and liver transplantation, collecting samples); (d) AUD and SARS-CoV-2 vaccination. Telemedicine/telehealth will undoubtedly be useful/practical tools even though it remains at an elementary level; the contribution of the family and of caregivers in the management of AUD patients will play a significant role; the multidisciplinary intervention involving experts in the treatment of AUD with specialists in the treatment of COVID-19 disease will need implementation. Thus, the COVID-19 pandemic is rapidly leading addiction specialists towards a new governance scenario of AUD, which necessarily needs an in-depth reconsideration, focusing attention on a safe approach in combination with the efficacy of treatment.
    MeSH term(s) Alcoholics Anonymous ; Alcoholism/epidemiology ; Alcoholism/therapy ; Ambulatory Care/organization & administration ; COVID-19/drug therapy ; COVID-19/epidemiology ; COVID-19/prevention & control ; COVID-19 Vaccines/therapeutic use ; Communicable Disease Control ; Delivery of Health Care/organization & administration ; Disease Susceptibility ; Drug Interactions ; Humans ; Immunosuppression Therapy/adverse effects ; Italy/epidemiology ; Liver Cirrhosis, Alcoholic/epidemiology ; Liver Cirrhosis, Alcoholic/therapy ; Liver Transplantation ; Recurrence ; SARS-CoV-2 ; Societies, Medical ; Telemedicine
    Chemical Substances COVID-19 Vaccines
    Language English
    Publishing date 2021-09-16
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1324314-7
    ISSN 1369-1600 ; 1355-6215
    ISSN (online) 1369-1600
    ISSN 1355-6215
    DOI 10.1111/adb.13090
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top